Isoniazid acetylation phenotyping in Saudi Arabs. - Wikidata - thesis-toulmin - TriplyDB

Isoniazid acetylation phenotyping in Saudi Arabs.

Isoniazid acetylation phenotyping in Saudi Arabs.

http://www.wikidata.org/entity/Q45105243

about

Prevention of isoniazid toxicity by NAT2 genotyping in Senegalese tuberculosis patients.Isoniazid-induced polyneuropathy in a tuberculosis patient - implication for individual risk stratification with genotyping?

P2860

Q41679231-385DFAEC-07CD-4484-950E-8EC7181BC840 Q41875502-3A7E0C5A-62C2-4150-A864-91B51CDD96BD

P2860

Isoniazid acetylation phenotyping in Saudi Arabs.

http://www.wikidata.org/entity/Q45105243

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Isoniazid acetylation phenotyping in Saudi Arabs.

@en

Isoniazid acetylation phenotyping in Saudi Arabs.

@nl

type

label

Isoniazid acetylation phenotyping in Saudi Arabs.

@en

Isoniazid acetylation phenotyping in Saudi Arabs.

@nl

prefLabel

Isoniazid acetylation phenotyping in Saudi Arabs.

@en

Isoniazid acetylation phenotyping in Saudi Arabs.

@nl

P1433

Q45105243-9B272D95-7105-46BD-A1AA-FEF87502D469

P1476

Q45105243-C469C4C3-A6FC-4441-AF18-581F7E872B4E

P2093

Q45105243-28AFDE3A-091C-4567-AA0A-8DB4FEF15C16

Q45105243-48FAC53E-5C02-4E66-AAE1-AAEB900D66BC

Q45105243-77D4ED02-69D6-46C5-87CD-B3096184C1E2

Q45105243-855DD6DC-0DC4-41A4-86A4-4802573272A1

Q45105243-CCE2359B-716A-4B88-A4FF-F611F509A356

Q45105243-FFA0F163-0821-41C6-820B-7D1FF9D361EE

P2860

Q45105243-2CD2F1AD-2711-4C11-B6CA-3955A9799B87

Q45105243-4B82D5D8-27AE-4C47-B126-BC6A7AC8BCB8

Q45105243-625AB606-0FE0-4182-B737-8DDF490BE5A8

Q45105243-E3A1DAF1-84F1-4275-AE7F-A6F3CE94C318

P304

Q45105243-7430FE62-BBC9-4841-9318-8D78991A1490

P31

Q45105243-C5FF6670-02C7-4F4F-AFDF-A3909EC8E9DA

P356

Q45105243-08EC9CF1-38CF-4617-8B7F-9599F7A18D4A

P433

Q45105243-25FF221B-870D-42C0-BDBB-D364EC74C896

P478

Q45105243-9CD6F711-2F6C-4029-A753-8DC1968BF68E

P577

Q45105243-6F70CCF2-635E-4083-BDB8-AA4258C4E35D

P5875

Q45105243-33FCFAB1-8AE8-407E-B5DD-40F6D1708B69

P698

Q45105243-8BC28F61-D4C3-4B1F-8654-A57CDDF607DA

P356

J.1365-2710.2004.00588.X

P1433

Journal of Clinical Pharmacy and Therapeutics

P1476

Isoniazid acetylation phenotyping in Saudi Arabs.

@en

P2093

Al-Faleh FZ

http://www.w3.org/2001/XMLSchema#string

Al-Wazzan A

http://www.w3.org/2001/XMLSchema#string

Ayoola EA

http://www.w3.org/2001/XMLSchema#string

Bawazir SA

http://www.w3.org/2001/XMLSchema#string

Matar KM

http://www.w3.org/2001/XMLSchema#string

Mayet AY

http://www.w3.org/2001/XMLSchema#string

P2860

N-acetyltransferase

N-acetylation phenotyping using dapsone in a Jordanian population

The enhanced bladder cancer susceptibility of NAT2 slow acetylators towards aromatic amines: a review considering ethnic differences.

Isoniazid hepatotoxicity among drug users: the role of hepatitis C.

P304

443-447

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2710.2004.00588.X

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2004-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8234696

http://www.w3.org/2001/XMLSchema#string

P698

15482388

http://www.w3.org/2001/XMLSchema#string